Newsletter Signup
Where current and emerging technology trends meet.
TecTrendsInformation Sources, Inc.
  | About TecTrends | Email Signup | Contact Us
 Live Search:
Live Search | Articles | Companies | TecTerms | Products
  Loading TecTrends Live Search - please wait... 
View Noteworthy Articles      PRNewswire
 
Company

Genentech Inc Products   
1 DNA Way
S San Francisco,  CA  94080-4990
United States
Telephone: (650) 225-1000
Fax: (650) 225-6000
URL: http://www.gene.com
Email: info@gene.com

Genentech Incorporated, founded in 1976 and based in San Francisco, California, develops anti-tumor and other biotherapeutic products. Its oncology, immunology, and tissue growth and repair products are used by millions of patients worldwide. Avastin (R) treats metastatic cancer of the colon and rectum. Herceptin (R) treats breast cancer tumors. Rituxan (R) treats non-Hodgkin's lymphoma and rheumatoid arthritis. The company's RAPTIVA (R) is used to treat plaque psoriasis, and the Xolair (R) product treats asthma. Genentech's Activase (R) is a tissue-plasminogen activator that dissolves blood clots. Nutropin (R) is a human growth hormone. Pulmozyme (R) treats cystic fibrosis. Genentech opened its 275,000 square foot Founders Research Center in 1992. The biotechnology research facility was expanded by an additional 280,000 square feet in 2003. The firm maintains three manufacturing facilities in California. It has an additional plant in Porrino, Spain. Genentech has applied for over 5,000 patents worldwide. The company is focusing on developing 20 new molecules and 15 new products by 2010. The firm invests approximately 20 percent of operating revenues into research programs. Genentech was founded by investor Robert A. Swanson and biochemist Dr. Herbert W. Boyer. The company and its technology have won recognition from 'Fortune.'

Org. Type: Corporation Equity Type: Public
Company Status: Active Date Founded: 1976
Symbol: NYSE:DNA

Products:
Avastin
Genentech Inc--Company News
Genentech Inc--Company Reference
Herceptin
Lucentis

TecTerms:
 


Home About TecTrends About Us Contact Us Privacy Statement Terms and Conditions

TecTrends | P.O. Box 8120 | Berkeley CA 94707 | (510) 525-6220 | Email: tectrends@tectrends.com
© 2006 INFORMATION SOURCES INC | All rights reserved.